Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · April 20, 2024

Dual GLP-1 and Glucagon Receptor Agonism Reduces Energy Intake in People With Type 2 Diabetes With Obesity

Diabetes, Obesity & Metabolism


Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes, Obesity & Metabolism
Dual glucagon-like peptide-1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity
Diabetes Obes Metab 2024 Apr 01;[EPub Ahead of Print], R Golubic, J Kennet, V Parker, D Robertson, D Luo, L Hansen, L Jermutus, P Ambery, M Ryaboshapkina, M Surakala, RC Laker, M Venables, A Koulman, A Park, M Evans

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading